PureHealth
Jul 18, 2019
PureHealth acquires LYT-100; Sosei raises USD 2.5 M
PureHealth acquires LYT-100 to treat lymphedema PureTech Health, a pioneer in the development of therapies for dysfunctions in the brain-immune-gut axis, has announced to acquire a clinical-stage drug, LYT-100 for the potential treatment of lymphatic and immunofibrotic diseases including lymphedema. The candidat...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
